CMRI: Capturing Physiologic Autonomic Data From Clinically Indicated Magnetic Resonance Imaging Scans in Children

Sponsor
Children's Hospital Medical Center, Cincinnati (Other)
Overall Status
Recruiting
CT.gov ID
NCT06110689
Collaborator
(none)
40
1
16
2.5

Study Details

Study Description

Brief Summary

The Fontan Procedure is a palliative surgical procedure used in pediatric patients with one functional ventricle. The procedure, a series of stepwise operations that alter cardiorespiratory physiology, separate the systemic and pulmonary circulations to create Fontan physiology, where the systemic venous blood flows passively and without ventricular thrust into the pulmonary circulation. The hallmark of the Fontan circulation is a sustained, abnormally elevated central venous pressure combined with decreased cardiac output, especially during periods of increased demands. Results of several studies in Fontan patients have shown reduced parasympathetic and sympathetic activity compared to controls. In children with congenital heart disease, a differential diagnosis of autonomic dysfunction may be part of their pathophysiology, a compensatory mechanism, a consequence of surgical procedures or a combination of these.

In children, measurement of ANS function is equally important. Children with single ventricle physiology (and other cardiac conditions) have routine surveillance and cardiac magnetic resonance (CMR) imaging to monitor for disease progression. While autonomic data is routinely collected and is available from these scans, these data are rarely, collected and analyzed; however, our group has shown feasibility. Therefore, autonomic data is usually unavailable in children. Despite the availability of agerelated normal values, the predictive power of autonomic activity is understudied in children and there are no published studies of quantification of autonomic data in this population.

Condition or Disease Intervention/Treatment Phase
  • Other: VU-AMS device

Study Design

Study Type:
Observational
Anticipated Enrollment :
40 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Capturing Physiologic Autonomic Data From Clinically Indicated Magnetic Resonance Imaging Scans in Children
Actual Study Start Date :
Oct 3, 2023
Anticipated Primary Completion Date :
Aug 1, 2024
Anticipated Study Completion Date :
Feb 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Fontan

Patients undergoing cardiac MRI for Fontan,

Other: VU-AMS device
Patients will wear the VU-AMS monitor prior to MRI.

Healthy controls

Patients undergoing thoracic MRI for chest wall deformity.

Other: VU-AMS device
Patients will wear the VU-AMS monitor prior to MRI.

Outcome Measures

Primary Outcome Measures

  1. 80% availability of respiratory sinus arrhythmia from cardiac MRI (magnetic resonance imaging) [Through MRI completion up to one hour]

    Data collected during MRI

Other Outcome Measures

  1. Describe difference in respiratory sinus arrhythmia in participants with Fontan [Through MRI completion up to one hour]

    Collection of data from the cardiac MRI

  2. Describe difference in respiratory sinus arrhythmia in participants with pectus [Through MRI completion up to one hour]

    Collection of data from the cardiac MRI

  3. Compare estimate of pre-ejection period (PEP) [Prior to MRI scan up to 10 minutes]

    Collection of data from VU-AMS monitor

  4. Compare estimate of pre-ejection period (PEP) [Through MRI completion up to one hour]

    Collection of data from the cardiac MRI

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 30 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ages 0 to ≤ 30 years

  • Baseline sinus rhythm (interventricular conduction delays and bundle branch blocks allowed); and undergoing CMR scan in which sequences containing timing of aortic valve opening (cine), vector cardiogram (VCG) and respiratory bellows use will be obtained

  • Fontan physiology - only for the Fontan group. Chest wall deformity or arrhythmogenic right ventricular cardiomyopathy for the healthy control group

Exclusion Criteria:
  • Patient or family refusal;

  • Contraindication to study procedures

  • Prior participation in the study (ie, we plan to sample without replacement)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cincinnati Children's Hospital Medical Center Cincinnati Ohio United States 45229

Sponsors and Collaborators

  • Children's Hospital Medical Center, Cincinnati

Investigators

  • Principal Investigator: Jamie Sinton, MD, Children's Hospital Medical Center, Cincinnati

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier:
NCT06110689
Other Study ID Numbers:
  • 2023-0400
First Posted:
Nov 1, 2023
Last Update Posted:
Nov 2, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 2, 2023